Steven Meikle is a Professor of Medical Imaging Physics and Head of the Imaging Physics Laboratory at the Brain and Mind Centre, University of Sydney. He also serves as Deputy Director (Preclinical) of Sydney Imaging and Deputy Director of the National Imaging Facility's Sydney node. His expertise spans advanced imaging technologies, with a focus on PET/SPECT instrumentation and molecular imaging. He holds a B.App.Sc.(Hons) from the University of Technology Sydney and a PhD from the University of New South Wales. Research focuses include developing novel PET systems like Open-field PET (for freely moving rodents) and Total Body PET, which enhance imaging sensitivity and enable real-time behavioral studies alongside brain function analysis. Collaborations include Tsinghua University (China) and UC Davis (USA). He leads projects on motion correction, quantitative imaging, and AI-driven analysis. Key achievements include over 180 peer-reviewed publications, editorial roles in Physics in Medicine and Biology , and leadership in professional societies. Awards include IEEE Senior Membership and Australian Institute of Physics Fellowship. Current student projects explore Total Body PET applications, motion correction, and radiopharmaceutical evaluation. Teaching roles include medical physics courses in diagnostic radiography and medical physics programs. He advises on imaging ethics, facility implementation, and translational research bridging basic science and clinical applications.
Caitriona M. O'Driscoll is Professor and Chair of Pharmaceutics at University College Cork's School of Pharmacy, Ireland. With over four decades of academic experience, she previously served as Head of the School of Pharmacy at UCC from 2003-2009 and 2010-2013. Her established drug delivery research team spans from pre-formulation through to production and manufacture of prototype delivery systems suitable for clinical trial, with strong industry links underpinning many research projects. Her research interests focus on translational drug delivery with emphasis on 'problem' drugs including poorly water soluble compounds and biopharmaceuticals like peptide/protein drugs, plasma DNA and siRNA. She develops nano-sized delivery constructs that are robust enough to survive processing, stable on storage, and achieve cell/site specific delivery in vivo. Greater than 40% of new chemical entities are poorly water soluble Biopharmaceuticals now approach 50% of all new drugs in development Major barrier is design of efficient delivery systems Special focus on oral drug delivery despite challenges Analysis of her recent publications reveals a strong emphasis on targeted nanodelivery systems for cancer therapy, particularly prostate and colorectal cancer, as well as neurodegenerative diseases like Huntington's. Her work demonstrates expertise in cyclodextrin-based nanoparticles, siRNA delivery, and disease-specific formulations that account for conditions like Crohn's disease that affect drug delivery. Scientific awards include: 'Person of the Year award' by Parenteral Drug Association (Ireland Chapter) in 2013 'Award for Professional Excellence' by Helix Health in 2007/2008 'Award for Pharmacist of the Year' by Helix Health in 2007/2008 With €10.5M in career research income and 25 PhDs graduated, Professor O'Driscoll's work has attracted funding from diverse sources including Science Foundation Ireland, Enterprise Ireland, and industry partners. Her research group maintains strong links with Pharmaceutical Chemistry and Process & Chemical Engineering at UCC, creating a unique strength for drug development research from design through to clinical trial. She has served as external examiner for multiple universities and as PhD thesis examiner at institutions worldwide. Her research team operates within UCC's drug delivery group, which has established expertise spanning from pre-formulation through to production and manufacture of prototype delivery systems. The group maintains strong industry connections and offers various PhD positions, focusing particularly on translational research with product-driven applications.
Dr. Changyou Chen is an Associate Professor in the Department of Computer Science and Engineering at the University at Buffalo, State University of New York. His research focuses on Multi-Modal Learning Foundation Models Deep Generative Models Large-scale Bayesian Sampling with applications in document understanding, music-AI integration, and molecular representation learning. Research Trends revealed through his recent publications include Optimizing Multimodal Large Language Models Developing Novel Retrieval-Augmented Generation Frameworks Creating Benchmark Datasets for Visual Text Understanding Advancing Diffusion Models with Domain-Specific Constraints across domains from music sheets to biomedical documents. Scientific Contributions : UB Young Investigator Award (2020) Architect of LoCAL Framework for Long Document Understanding Co-developer of MusiXQA Benchmark Pioneering Work in Probability Contrastive Learning Academic Leadership includes mentoring 10+ graduate students and serving as Area Chair for major AI conferences (ICML, NeurIPS, AAAI, IJCAI). His Labs develop scalable solutions for multimodal reasoning, with recent work demonstrating practical GPU memory optimization through LoRA adapter sharing.
Taylor Ware is an Associate Professor in Biomedical Engineering and Materials Science & Engineering at Texas A&M University's College of Engineering, holding the Cain Faculty Fellowship. Her research focuses on designing structured biomaterials and medical devices using stimuli-responsive polymers for clinical applications. Education: Ph.D. in Materials Science and Engineering, The University of Texas at Dallas, 2013 Research Interests: Dr. Ware pioneers the development of liquid crystal elastomers as artificial muscles and implantable electronics substrates, engineered living materials for infection treatment, and directed self-assembly of hydrogels. Her lab specializes in polymer formulation, thermomechanical testing, and microfabrication. Key research thrusts include: Smart elastomers, hydrogels, and composites for dynamic medical devices Programming liquid crystalline polymers for shape-morphing applications Engineered living materials that respond to biomolecular cues in urinary tract environments Publication Trends: Recent work (2023-2025) demonstrates convergence of materials science, microbiology, and medical device engineering. Her group advances liquid crystal elastomers for soft robotics and implantable electronics, develops engineered living materials for UTI treatment using microbial competition, and creates novel hemostats and urethral support devices. Publications emphasize translational applications in urology, wound healing, and neural interfaces. Scientific Awards: Invited Participant, NAE Japan-USA Frontiers of Engineering Bilateral (2023) Senior Member, National Academy of Inventors (2022) NSF CAREER Award (2018) Air Force Young Investigator Award (2017) NSF Graduate Research Fellowship (2011) Fellow of AIMBE (American Institute for Medical and Biological Engineering) Advising and Grants: Dr. Ware leads the Ware Lab with significant funding including an NIH R01 grant (with UT Dallas and Case Western collaborators) and the NSF CAREER award. Her lab mentors postdoctoral fellows like Mustafa (winner of a prestigious postdoctoral fellowship) and graduate students. Current projects are supported by the NSF Engineering Research Center HAND, focusing on advanced materials for healthcare applications. Laboratory and Teams: The Ware Lab collaborates globally and is featured in Texas Monthly, Houston Chronicle, and National Geographic for breakthroughs in engineered living materials. As part of the NSF HAND ERC, the lab develops dynamic materials for stress urinary incontinence treatment and collaborates with medical institutions on UTI therapies using engineered E. coli strains.
Marjo Yliperttula is a Professor at the Department of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki. She serves as a supervisor in the Doctoral Programmes in Biomedicine, Drug Research, and Materials Research and Nanosciences, with expertise in biomaterials and pharmaceutical technology. Her research focuses on nanofibrillated cellulose (NFC) hydrogels for wound healing and drug delivery, extracellular vesicle (EV) engineering for therapeutic applications, and freeze-drying technologies for biomaterial preservation. Key contributions include NFC-based wound dressings that enhance platelet-rich plasma release (2024), Raman spectroscopy methods for monitoring freeze-drying-induced mutarotation (2024), and tandem chromatography techniques for high-purity EV isolation (2023). Her work bridges pharmaceutical sciences with regenerative medicine, emphasizing translational applications in chronic wound treatment and targeted drug delivery. Recent publications (2022-2025) reveal three dominant trends: (1) Optimization of NFC hydrogels for controlled drug release and tissue regeneration, (2) Advanced characterization of EV phenotypes under hypoxic conditions for improved therapeutic efficacy, and (3) Development of analytical methods (Raman spectroscopy, chromatography) to address manufacturing challenges in biopharmaceuticals. These themes reflect her group's commitment to solving critical problems in biomaterial stability, EV-based delivery, and precision wound care. Professor Yliperttula has supervised 10 doctoral theses, including recent work on NFC for skin substitutes (Elle Koivunotko), freeze-drying of hydrogels (Arto Merivaara), and mesenchymal stromal cells for wound healing (Jasmi Snirvi). She currently leads the Academy of Finland-funded GeneCellNa project (2024-2026) on gene/cell/nanotherapy for chronic diseases and a Finnish Red Cross project (2023-2024) on NFC for blood products, with cumulative project funding spanning 18 initiatives since 2005. She heads the Biopharmaceuticals Group within the Drug Research Program, fostering collaborations across pharmaceutical biosciences, materials science, and clinical medicine to advance next-generation therapeutic platforms.
Steven R. Caliari is an Associate Professor in the Department of Chemical Engineering with a secondary appointment in Biomedical Engineering at the University of Virginia’s School of Engineering and Applied Science. He serves as the ChE Graduate Program Director and is a SEAS Copenhaver Fellow (2023). His research focuses on designing biomaterials to study cell-microenvironment interactions, addressing challenges in disease and tissue engineering. He holds a B.S. (2007, University of Florida), M.S. (2010), and Ph.D. (2013) in Chemical Engineering from the University of Illinois, followed by an NIH postdoctoral fellowship at the University of Pennsylvania. His research interests include biomaterials, mechanobiology, musculoskeletal tissue engineering, and advanced manufacturing for biological applications. His lab has pioneered viscoelastic hydrogel platforms and conductive collagen scaffolds, supported by NIH, NSF, DoD, and industry grants. Notable awards include the NSF CAREER Award (2021) and NIH MIRA (2020). Grants: NIH (NIGMS), NSF CAREER, V Foundation, UVA-Coulter Partnership Courses: Tissue Engineering (BME/CHE 4417), Transport Processes I (CHE 3321) Labs: Caliari Lab focuses on biomaterial design and mechanobiological studies His work bridges fundamental science and translational applications, emphasizing dynamic material systems for regenerative medicine and disease modeling.
Professor James Barlow is Co-Director of Imperial College London's Centre for Sectoral Economic Performance and holds a Professorship in the Department of Economics and Public Policy at the Imperial College Business School. He also serves as Academic Director for the MBA programme and Visiting Professor at Halmstad University (Sweden) and Honorary Professor at UCL Bartlett Real Estate Institute. His research focuses on structural challenges in healthcare innovation, housing, and construction sectors, with a particular emphasis on embedding innovations into healthcare systems. Barlow's education includes a background in geography and economics from the London School of Economics. He has held previous roles at the University of Westminster and Policy Studies Institute. His advisory work spans governments, healthcare organizations, and industries including medical technology and pharmaceuticals. He contributes to major initiatives like AGE-WELL (Canada) and the Industry Commons Foundation (Sweden). Research interests include healthcare innovation ecosystems, institutional logics, and frugal innovation. His recent book *Managing Innovation in Healthcare* synthesizes his work. He collaborates across disciplines, addressing challenges in telehealth, AI integration, and regulatory frameworks post-Brexit. Key affiliations include the Centre for Health Economics and Policy Innovation, Policy Innovation Research Unit (PIRU), and the NIHR Health Tech Research Centre. His work bridges academic research with practical policy and industry solutions, emphasizing scalable and sustainable business models.
Christopher E. Carr is an Assistant Professor at the Daniel Guggenheim School of Aerospace Engineering in the College of Engineering at Georgia Institute of Technology, with a secondary appointment in the School of Earth and Atmospheric Sciences in the College of Sciences. He runs the Planetary eXploration Lab (PXL) and is a member of the Space Systems Design Lab (SSDL). His work focuses on searching for and expanding the presence of life beyond Earth while enabling a sustainable human future in space environments. Dr. Carr's research interests include: Astrobiology and space biology Development of life detection instruments Microbial habitability in extreme environments Molecular evolution and biosignature detection Miniaturization and integration of scientific instrumentation Interplanetary mission design Micro and nano device engineering for space applications His recent publications demonstrate a strong focus on life detection technologies, planetary exploration, and space biology. The articles span topics from developing biosignature detection methods to analyzing microbial survival in extreme environments, with particular attention to Mars, Venus, and Europa exploration. Scientific awards and recognitions include: Scott M. Johnson Fellow in the U.S. Japan Leadership Program Dr. Carr's laboratory affiliations include: Planetary eXploration Lab (PXL) Space Systems Design Lab (SSDL) He is affiliated with the Center for Space Technology and Research at Georgia Tech.
Omer T Inan is the Regents Entrepreneur Endowed Chair and Assistant Professor at the School of Electrical and Computer Engineering (ECE) at Georgia Institute of Technology. His work bridges biomedical engineering and wearable technology, focusing on non-invasive physiological monitoring for chronic disease management. He holds a Ph.D. in Electrical Engineering from Stanford University (2009) and previously worked at Countryman Associates (2007-2013) as Chief Engineer, developing professional audio systems. Education: B.S., M.S., Ph.D. in Electrical Engineering, Stanford University (2004-2009) His research interests include medical devices for home-based cardiovascular monitoring, musculoskeletal sound analysis, and neuromodulation of stress responses. He has pioneered technologies for heart failure patients, PTSD treatment, and osteoarthritis diagnostics. Recent publications highlight innovations in AI-driven cardiac parameter estimation, motion artifact removal in seismocardiograms, and multimodal stress tracking via wearables. His work spans biomedical signal processing, clinical translation, and portable diagnostic systems. Scientific Awards 2024 IEEE Fellow 2023 IEEE Distinguished Lecturer 2023 American College of Cardiology Fellow 2022 American Institute for Medical and Biological Engineering Fellow 2021 Academy Award for Technical Achievement (The Oscars) 2018 ONR Young Investigator Award 2018 NSF CAREER Award At Georgia Tech, Inan leads the Inan Research Lab, which develops technologies for physiological monitoring and modulation. Projects include musculoskeletal sound analysis for joint health, non-invasive cardiovascular sensing, and neuromodulation to treat PTSD via vagal nerve stimulation.
Paras N. Prasad is a SUNY Distinguished Professor with joint appointments in Physics, Chemistry, Medicine, and Electrical Engineering at the University at Buffalo. He serves as Executive Director of the Institute for Lasers, Photonics and Biophotonics (ILPB), which he founded in 1999. Dr. Prasad holds the Samuel P. Capen Chair of Chemistry and has pioneered interdisciplinary research at the interface of photonics, nanotechnology, and biomedicine. Education: BSc, Bihar University, India (1964) MSc, Bihar University, India (1966) PhD, University of Pennsylvania (1971) Postdoctoral Fellow, University of Michigan (1971-74) Research Focus: Dr. Prasad's multidisciplinary research spans photonics, nanophotonics, and biophotonics, with emphasis on nonlinear optical processes in nanostructured materials. His work develops photonic technologies for information processing, medical imaging, and cancer therapy through nanoparticle-based drug delivery systems and diagnostic platforms. The ILPB laboratory features state-of-the-art instrumentation for advanced optical research. Publication Trends: Recent articles demonstrate strong focus on nanomedicine applications, particularly cancer theranostics using functional nanoparticles. Key themes include drug delivery systems, chiral photonic materials, bioimaging technologies, and nanoparticle synthesis techniques. The research consistently bridges fundamental materials science with translational medical applications. Honors and Awards: SPIE Gold Medal (2016) IEEE Photonics Society William Streifer Award (2021) American Chemical Society Peter Debye Award (2018) OSA Michael Feld Biophotonics Award (2017) IEEE Pioneer Award in Nanotechnology (2017) Fellow of National Academy of Inventors (2016) Guggenheim Fellowship (1997) Leadership: As ILPB Executive Director, Dr. Prasad leads multidisciplinary teams developing photonic technologies with applications in healthcare, energy, and communications. His research has generated nine spin-off companies, including Nanobiotix currently in advanced cancer therapy trials.
Hatice Altug is a Full Professor at EPFL's Institute of Bioengineering within the School of Engineering, where she leads the Bionanophotonic Systems Laboratory. Her research integrates nanophotonics, plasmonics, and microfluidics to develop advanced biosensors for real-time molecular diagnostics. She holds dual roles in EPFL's doctoral programs and academic committees. Education: PhD in Applied Physics, Stanford University (2000-2007) B.S. in Physics, Bilkent University (1996-2000) Her research centers on creating label-free, high-sensitivity optical biosensors using nanophotonic technologies. Key innovations include dielectric metasurfaces for mid-infrared spectroscopy, AI-enhanced detection platforms, and portable nanoplasmonic imagers for point-of-care diagnostics. Her work bridges fundamental light-matter interactions with clinical applications like sepsis monitoring and cancer biomarker detection. Her publications emphasize nanophotonic biosensor design, metasurface applications, and single-cell analysis. Recent trends show increased focus on AI integration, vibrational spectroscopy, and wafer-scale manufacturing for clinical translation. Awards & Honors: Optical Society Fellow (2020) Presidential Early Career Award (PECASE, 2011) ERC Consolidator Grant (2016) IEEE Photonics Society Young Investigator Award (2011) She mentors numerous PhD students and leads interdisciplinary teams developing optofluidic platforms. Her laboratory pioneers nanoplasmonic microarrays and collaborates globally on projects like neurodegenerative disease biomarker detection. She co-directs EPFL's doctoral program in photonics and champions women in STEM through executive roles in diversity initiatives.
Maartje Bastings is an Associate Professor at the École Polytechnique Fédérale de Lausanne (EPFL) , leading the Programmable Biomaterials Laboratory (PBL) within the School of Engineering (STI) . She holds additional affiliations with the Institute of Materials (IMX) , IBI-STI (Bioengineering), and supervises doctoral programs in Biotechnology and Biological Engineering ( EDBB-GE ) and Materials Science and Engineering ( EDMX-GE ). Her research focuses on DNA-based supramolecular materials engineered to achieve dynamic reciprocity —a two-way interaction between synthetic materials and biological systems. By leveraging DNA as a programmable scaffold, she investigates structural mechanics, valency control, and geometric constraints governing self-assembly and cell communication at bio-interfaces. Key applications include immune system modulation, diagnostics , and vaccine development . Analysis of her 15 most recent publications reveals a focus on multivalent interactions for T-cell activation, spatial patterning in immune signaling, and engineered coatings for DNA origami stability. Subfields span T cell receptor engineering , nanoscale protein dynamics , stimuli-responsive biomaterials , and bio-inspired therapeutic design . PhD Students: Chen Yuduo Hendrickx Pauline Bart M. Kononenko Artem Li Shujie Lou Yameng Meyer Pitt Narita Minako Rousseau Benjamin Bila Hale Caroprese Vincenzo Comberlato Alice Kurisinkal Eva Eugene Paloja Kaltrina Rodríguez Franco Hugo José Tekin Cem Wong Siu Ho Contact: maartje.bastings@epfl.ch
A.T. Charlie Johnson serves as the Rebecca W. Bushnell Professor of Physics and Astronomy at the University of Pennsylvania's School of Arts & Sciences, where he has been a standing faculty member since 1994. His research program focuses on nanoscale systems and has established him as a leading figure in condensed matter physics, earning recognition from major scientific societies. His educational foundation includes: Ph.D. in Physics from Harvard University (1990) B.S. in Physics from Stanford University (1984) Professor Johnson's research centers on the development and application of atomic-layer nanomaterials, particularly graphene and transition metal dichalcogenides , for fundamental studies of transport phenomena and practical biosensor applications. His group employs advanced nanofabrication techniques at Penn's Singh Center for Nanotechnology to create devices that leverage biological molecules for chemical recognition in disease diagnosis, security screening, and environmental monitoring. This work bridges condensed matter physics with biomedical engineering , yielding innovative solutions for real-world detection challenges. Analysis of his 2023-2025 publications reveals three dominant research thrusts: (1) scalable graphene-based biosensor development for medical diagnostics, (2) exploration of quantum phenomena like Klein tunneling in novel nanoelectromechanical systems, and (3) interdisciplinary applications spanning oncology, planetary science, and fetal medicine. His work consistently emphasizes materials synthesis , device integration , and practical translation of nanoscale phenomena. His scientific contributions have been recognized with prestigious honors: Defense Science Study Group Fellow (2018-2019) Fellow of the American Association for the Advancement of Science (2017) Fellow of the American Physical Society (2011) Lindback Foundation Award for Distinguished Teaching (2003) David and Lucille Packard Foundation Fellowship (1994-1999) As an educator, Professor Johnson has mentored numerous graduate students and postdoctoral researchers, with notable alumni like Michael Biercuk (founder of Q-CTRL). His research has been supported through significant leadership roles including Director of the Nano/Bio Interface Center (2014-2017) and Packard Fellowship funding, enabling sustained innovation in nanotechnology. His group actively collaborates across disciplines to advance both fundamental understanding and practical applications of nanomaterials. Based at the Singh Center for Nanotechnology, Johnson leads a dynamic research team utilizing state-of-the-art facilities for nanofabrication and characterization. His laboratory maintains strong campus collaborations through secondary appointments in Electrical and Systems Engineering and Materials Science and Engineering, fostering an interdisciplinary environment for developing next-generation nanoscale devices.
Scott L. Diamond is the Arthur E. Humphrey Professor of Chemical and Biomolecular Engineering and Bioengineering at the University of Pennsylvania's School of Engineering and Applied Sciences. He serves as Director of the Penn Center for Molecular Discovery, Director of the Penn Biotechnology Masters Program (one of the largest in the country with over 130 students), and Associate Director of the Institute for Medicine and Engineering (IME). His laboratory is located in the Roy and Diana Vagelos Laboratories at 3340 Smith Walk, 1020 Vagelos Research Laboratories, Philadelphia, PA. Diamond's research spans multiple interconnected fields in blood biology and biotechnology. His work focuses on mechanobiology, thrombolysis, coagulation, bioadhesion, gene therapy, drug/device development, proteomics, drug discovery, systems biology, and microfluidics. His laboratory has developed numerous specialized microfluidic devices for studying blood clotting under various flow conditions, including 8-channel devices for high-throughput clotting assays, side-view devices for clot structure analysis, stenosis devices for high shear clotting assays, and impingement-post devices for studying von Willebrand factor fibers. Diamond's research group has pioneered approaches to model and predict blood function using systems biology principles. His team has developed computational models that integrate reaction-transport phenomena with platelet signaling networks to predict thrombus formation under flow. These models have enabled the development of 'virtual blood' computer simulations that can predict the effectiveness of anticoagulation drugs for individual patients, contributing significantly to personalized medicine approaches in hemostasis and thrombosis. His extensive publication record demonstrates a consistent focus on understanding the fundamental mechanisms of blood clot formation and dissolution. Recent work has emphasized microfluidic approaches for point-of-care diagnostics, patient-specific modeling of platelet function, and the development of novel therapeutic strategies for thrombotic disorders. His research bridges engineering principles with clinical hematology to address significant challenges in cardiovascular medicine. NSF National Young Investigator Award NIH FIRST Award American Heart Association Established Investigator Award AIChE Allan P. Colburn Award George Heilmeier Excellence in Research Award Elected Fellow of the Biomedical Engineering Society (BMES) Diamond has secured significant research funding, including a $2.8 million NIH grant for 'Blood Systems Biology' and a $9.5 million NIH grant for the Penn Center for Molecular Discovery. His laboratory has developed numerous microfluidic devices for blood analysis and has collaborated extensively with clinicians and industry partners. Diamond has served on advisory committees for NSF, NIH, AHA, and NASA, and has consulted extensively for industry and government. With over 180 publications and patents, his work has significantly advanced the understanding of blood clotting mechanisms and the development of diagnostic and therapeutic approaches for thrombotic disorders.
Vernita Gordon is an Associate Professor in the Department of Physics at the University of Texas at Austin (since 2018), previously serving as an Assistant Professor there from 2010 to 2018. She holds a Ph.D. in Physics from Harvard University (2003) and a B.Sc. in Physics and Mathematics from Vanderbilt University (1997). Her research focuses on understanding how physical characteristics like mechanics and spatial structure influence bacterial biofilms, particularly their interactions with the immune system and resistance to antibiotics. She has pioneered techniques such as laser trapping to manipulate biofilm structures and studies radiation effects on bacteria like Deinococcus radiodurans . Education: Ph.D. in Physics, Harvard University (2003) B.Sc. in Physics and Mathematics, Vanderbilt University (1997) Research Interests: Dr. Gordon’s work integrates biophysics, microbiology, and materials science to explore biofilm mechanics, bacterial mechanosensing, and radiation biology. Key areas include: How biofilm mechanics resist immune clearance and antibiotic treatment Role of surface stiffness and shear stress in biofilm initiation Radiation resistance mechanisms in Deinococcus radiodurans Development of tools like laser trapping to study biofilm structure Key Achievements: Recipient of the Elizabeth B. Gleeson Professorship (2023) and Texas Mindset Initiative Fellowship (2023) Provost’s Teaching Fellow (2020–2024) and multiple teaching awards Funded by NSF, NIH, and Cystic Fibrosis Foundation Published over 60 peer-reviewed articles, including in Nature , PNAS , and Biophysical Journal Advising & Outreach: She mentors graduate students in Physics, Microbiology, and Biomedical Engineering, emphasizing interdisciplinary training. Her group actively recruits undergraduates and collaborates with industry partners like Solvay and the College of Pharmacy. Outreach includes lesson plans for high school STEM education and community science initiatives. Labs & Collaborations: Her lab uses advanced microscopy, microrheology, and computational modeling. Key collaborations include work with the Contreras Lab (UT Austin Chemical Engineering) on radiation-resistant bacteria and the Raizen Lab (UT Austin Physics) on self-sterilizing surfaces.
